| Literature DB >> 28571949 |
Dariusz Kałka1, Jana Gebala2, Ryszard Smoliński3, Lesław Rusiecki4, Witold Pilecki4, Romuald Zdrojowy5.
Abstract
Patients with cardiovascular disease (CVD) are prone to developing erectile dysfunction (ED) owing to the common risk factors and pathogenesis underlying ED and CVD. As a result, ED affects nearly 80% of male patients with CVD. The efficacy of phosphodiesterase type 5 inhibitors, vacuum erection devices, or intracavernosal injection of vasodilating agents is well established in the treatment of ED; however, their use is limited. Low-energy shock wave therapy is a novel modality that may become a causative treatment for ED. This review aims to assess the efficacy and safety of low-energy shock wave therapy in the treatment of ED in men with CVD.Entities:
Mesh:
Year: 2017 PMID: 28571949 DOI: 10.1016/j.urology.2017.05.030
Source DB: PubMed Journal: Urology ISSN: 0090-4295 Impact factor: 2.649